The analysis of the correlation between PDK4 expression and BCR in primary and metastatic tumors demonstrated its ability to predict disease recurrence independently of diagnostic risk factors, such as grading, staging, and PSA levels, thus suggesting its potential as a promising independent prognostic biomarker for distinguishing between a good and bad prognostic PCa. This evidence concerns the gene PDK4 and posterior cortical atrophy.